Athena Countouriotis - President & CEO, Director at Turning Point Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
TPTX
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Athena Countouriotis since 11/5/2023

Holdings reported by Athena Countouriotis for Turning Point Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $76.00 Aug 17, 2022 Direct
Stock Option (right to buy) 0 Aug 17, 2022 Direct Common Stock

Transactions reported by Athena Countouriotis for Turning Point Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.